The compounder 
AVGO has declined almsot 20% from ATHs. The stock is trading around $325 as we speak, currently testing the 100 SMA, if it breaks below, a gap could be filled around $310:$300.
Keys:
A disparity between the trailing P/E of 71 and the anticipated forward 24x suggests that the company is expecting a massive earnings boom.
PEG of 0.69 is suggesting an undervalued stock price to its growth.
A fortress balance sheet with a profit margin of 36.20% & gross margin of 64,71% & EPS next y of 38,21%
AVGO has declined almsot 20% from ATHs. The stock is trading around $325 as we speak, currently testing the 100 SMA, if it breaks below, a gap could be filled around $310:$300. Keys:
A disparity between the trailing P/E of 71 and the anticipated forward 24x suggests that the company is expecting a massive earnings boom.
PEG of 0.69 is suggesting an undervalued stock price to its growth.
A fortress balance sheet with a profit margin of 36.20% & gross margin of 64,71% & EPS next y of 38,21%
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。